VYNE Therapeutics CEO Steven Basta's 2018 pay jumps 156% to $2.6M
VYNE Therapeutics reports 2018 executive compensation
By ExecPay News
Published: May 10, 2019
VYNE Therapeutics reported fiscal year 2018 executive compensation information on May 10, 2019.
In 2018, three executives at VYNE Therapeutics received on average a compensation package of $1.7M, a 97% increase compared to previous year.
Average pay of disclosed executives at VYNE Therapeutics
Steven Basta, Chief Executive Officer, received $2.6M in total, which increased by 156% compared to 2017. 66% of Basta's compensation, or $1.7M, was in option awards. Basta also received $319K in bonus and $580K in salary.
Mary Spellman, Chief Medical Officer, received a compensation package of $1.3M, which increased by 113% compared to previous year. 60% of the compensation package, or $795K, was in option awards.
Kristine Ball, Chief Financial Officer, earned $1.3M in 2018, a 27% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on May 10, 2019.